7 November 2018 - Deborah Wilkes
Swedish probiotics specialist Probi, ingredients company ChromaDex and the UK's Company Chemists' Association (CCA) have all recently announced people changes.
Probi names new chief financial officer
Probi has appointed Henrik Lundkvist as chief financial officer with effect from 7 January 2019. He joins the Swedish probiotics specialist from GCE Group, the manufacturer of gas control equipment, where he has been chief financial officer since 2015.
Lundkvist will replace Jörn Andreas who recently announced he was leaving Probi for "personal reasons".
Probi has also just appointed a new chief executive officer. Tom Rönnlund is joining from Norwegian pharmaceutical company Navamedic (click here to read the News story).
ChromaDex recruits Matthew Roberts
ChromaDex has hired Matthew Roberts as chief scientific officer and senior vice president of innovation with immediate effect.
The US-based ingredients company pointed out that Roberts had more than 30 years of experience in scientific innovation and product development. He has worked for Abbott Nutrition, Nestlé, Pharmavite and The Nature's Bounty Company.
Roberts has been a member of the ChromaDex Scientific Advisory Board for two years.
CCA taps NHS experience
The UK Company Chemists' Association (CCA) has appointed John Bacon as its new chair.
The CCA said Bacon had more than 30 years of experience in the National Health Service (NHS) and had held a series of senior posts at the regional and national level. Bacon was head of the NHS in London, and was a director general in the Department of Health with responsibility for day-to-day management of the NHS in England.
Bacon takes over from Margaret MacRury, superintendent director of Rowlands Pharmacy, who held the position on an interim basis.
Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE